We respond to a wide range of needs from uneven reaction development to GMP manufacturing! Providing solutions to our customers' "problems."
The majority of pharmaceuticals are said to be chiral compounds. Spera Pharma provides solutions to customers' "problems" related to chiral compounds by comprehensively utilizing chiral technologies (asymmetric catalytic technology, chiral column technology, diastereomer salt technology, enzyme technology, etc.). In particular, the asymmetric hydrogenation reaction technology using metal catalysts is at a world-class level and has a proven track record of application in the production of many compounds. 【Features】 ■ Responding to a wide range of needs from the development of novel asymmetric reactions to GMP manufacturing ■ Screening utilizing a library of approximately 200 types of enzymes is possible ■ Screening of diastereomer salt crystals using a library of approximately 300 types of optically active acids and bases is also conducted *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.